Clinical trials
Completed Phase 1/2 trials in Ukraine
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eisai Inc. | 3 |
| Epizyme, Inc. | 2 |
| Pfizer | 2 |
| Agenus Inc. | 1 |
| Ascenta Therapeutics | 1 |
| Boston Pharmaceuticals | 1 |
| Daiichi Sankyo | 1 |
| Dr. Reddy's Laboratories Limited | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| Immune Biosolutions Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 4 |
| Lupus Erythematosus, Systemic | 3 |
| Lymphoma, Follicular | 3 |
| Arthritis, Rheumatoid | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Lung Neoplasms | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.